OpenScience.ink

2 weeks ago • Primary care diabetes

Use of combined basal insulin and GLP-1 drugs in Asians with type 2 diabetesUse of fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Asians with type 2 diabetes.

📖 Top 30% JournalArticle

2 weeks ago • Current atherosclerosis reports

Oral Medications That Use Gut Hormones to Help Control WeightOral Incretin-Based Therapies for Weight Management.

🎖️ Top 10% JournalArticle

2 weeks ago • Pharmaceutical research

Semaglutide Absorption: Current Limits, New Formulation Advances, and Future PossibilitiesSemaglutide Bioavailability: Limitations, Formulation Innovation and Future Opportunities.

📖 Top 20% JournalArticle

2 weeks ago • Food research international (Ottawa, Ont.)

Self-Propelled Oral Delivery System Combining Rapeseed Protein Peptide and Liraglutide to Boost Insulin and Lower Blood SugarOral Janus nanomotor covalent conjugation rapeseed protein-derived DPP-IV inhibitory peptide and liraglutide: A self-propelled targeted delivery system for promoting insulin secretion and glucose-lowering.

🎖️ Top 10% JournalArticle

2 weeks ago • Pharmaceutical research

Comparing the Structure and Lab Function of Synthetic Liraglutide with a Natural Reference VersionAn Orthogonal Framework for Higher-Order Structural and In Vitro Functional Comparability of Chemically Synthesized Liraglutide Relative to an rDNA-Origin Reference Product.

📖 Top 20% JournalArticle

2 weeks ago • Molecular metabolism

Semaglutide’s effects on male and female rat reproductive systems compared to equal calorie reductionBeyond Weight Loss: Disentangling the Direct Effects of Semaglutide vs Equivalent Calorie Restriction on Reproductive Systems of Male and Female Rats.

🥉 Top 5% JournalArticle

2 weeks ago • Ophthalmology. Retina

Use of GLP-1 Drugs and Risk of Sudden Optic Nerve Damage in People with Type 2 DiabetesGLP1-RA Use and Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes.

🥉 Top 5% JournalArticle

2 weeks ago • JAMA otolaryngology-- head & neck surgery

Glucagon-Like Peptide-1 Receptor Agonists and Their Potential Role in Obstructive Sleep ApneaGlucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea: A Review.

🎖️ Top 10% JournalArticle

2 weeks ago • Respiratory medicine

Lung response to diabetes treatment using GLP-1 receptor agonists in adults with cystic fibrosis: factors linked to better lung functionPulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV1.

📖 Top 20% JournalArticle

2 weeks ago • JAMA psychiatry

Use of GLP-1 Receptor Agonist Medications in People With and Without Serious Mental IllnessGLP-1 Receptor Agonist Prescriptions Among People With and Without Serious Mental Illness.

🥇 Top 1% JournalArticle

2 weeks ago • Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Changes in methods used for weight loss before body shaping surgeryTrends in preoperative weight loss modalities among patients receiving body contouring surgery.

📖 Top 20% JournalArticle

2 weeks ago • Gut and liver

Gastroesophageal Reflux Disease Linked to GLP-1 Receptor Agonists: A Multi-Country Drug Safety AnalysisMulti-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study.

🎖️ Top 10% JournalArticle

2 weeks ago • Kidney research and clinical practice

Incretin-based treatments for diabetic kidney disease and their role in improving heart, kidney, and metabolism healthIncretin-based therapies in diabetic kidney disease: toward integrated cardio-kidney-metabolic disease modification.

📖 Top 20% JournalArticle

2 weeks ago • Clinical spine surgery

Use of Glucagon-Like Peptide-1 Drugs and Vertebral Fracture Risk in Women Over 50 with OsteoporosisInvestigating the Relationship Between Glucagon-Like Peptide-1 Receptor Agonist Use and Incidence of Vertebral Fractures in Female Patients Aged Over 50 Years With Osteoporosis: A Propensity-Matched Analysis.

📖 Top 30% JournalArticle

2 weeks ago • Kidney360

Metabolic Changes After Sugar Test and Insulin Treatment in Chronic Kidney DiseaseMetabolomic Responses to Oral Glucose Tolerance Test and Hyperinsulinemic-euglycemic Clamp in CKD.

📖 Top 20% JournalArticle

2 weeks ago • Journal of diabetes investigation

Type 1 Diabetes and Obesity: How They Affect the Body and Treatment OptionsType 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.

📖 Top 20% JournalArticle

2 weeks ago • General psychiatry

Higher natural levels of glucagon-like peptide-1 linked to brain inflammation and amyloid buildup in Alzheimer's diseaseElevated endogenous glucagon-like peptide-1 as a novel Alzheimer's disease biomarker associated with neuroinflammation and Aβ pathology.

🎖️ Top 10% JournalArticle

2 weeks ago • JAMA pediatrics

Gallbladder Problems and Treatment with GLP-1 Medicines in Teens and Young AdultsBiliary Events and GLP-1 Receptor Agonist Therapy in Adolescents and Young Adults.

🥇 Top 1% JournalArticle

2 weeks ago • Annals of internal medicine

How Well and How Safely Weight-Loss Drugs Targeting Glucagon-like Peptide-1 Work in Adults Without DiabetesEfficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

🥈 Top 2% JournalArticle

2 weeks ago • Aesthetic plastic surgery

Psychosocial Effects and Appearance Expectations in Women Having Body Shaping After Weight Loss from GLP-1 Compared to After Weight Loss SurgeryCritical Insights on "Psychosocial Outcomes and Aesthetic Expectations in Female Patients Undergoing Body Contouring After GLP-1-Induced Weight Loss: A Prospective Pilot Comparative Study with Post-Bariatric Patients".

📖 Top 20% JournalLetter

2 weeks ago • Annals of internal medicine

Tirzepatide lowers blood sugar and weight more than intensified usual care after 2 years in adults with early uncontrolled type 2 diabetesIn adults with early uncontrolled T2D, tirzepatide vs. intensified conventional care reduced HbA1c levels and weight at 2 y.

🥈 Top 2% JournalArticle

2 weeks ago • Gut and liver

Current and New Treatments for Fatty Liver Disease Linked to Metabolic ProblemsMetabolic Dysfunction-Associated Steatotic Liver Disease: Current Treatment Strategies and Novel Therapies.

🎖️ Top 10% JournalArticle

2 weeks ago • International journal of pharmaceutics

Using a temperature-sensitive nanoparticle to deliver Semaglutide through the nose: development, testing, and biological evaluationIntranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation.

📖 Top 20% JournalArticle

2 weeks ago • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Predicting human drug effects using combined early-stage data shown with a GLP-1 receptor activatorM4 drug discovery: Human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist.

📖 Top 30% JournalArticle

3 weeks ago • EClinicalMedicine

How drugs that activate GLP-1 receptors may help reduce binge eating in people with obesityThe effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis.

🥈 Top 2% JournalArticle

3 weeks ago • Therapeutics and clinical risk management

Safe Use and Surgery Risk Management of GLP-1 Medicines: A Pharmacist-Guided Approach for Personalized CareMedication Safety and Perioperative Risk Management of GLP-1 Receptor Agonists: A Pharmacist-Led Framework for Individualized Care.

📖 Top 30% JournalArticle

3 weeks ago • JAMA network open

Stopping Semaglutide Treatment for Weight LossDiscontinuation of Semaglutide Therapy for Obesity Management.

🥈 Top 2% JournalArticle

3 weeks ago • Maturitas

Incretin-based treatments for obese women during and after menopause: expert recommendations from the Spanish Menopause SocietyIncretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society.

📖 Top 20% JournalArticle

3 weeks ago • British journal of clinical pharmacology

New treatment options for fatty liver disease linked to metabolismNew therapeutic options for metabolic-associated steatotic liver disease.

📖 Top 20% JournalArticle

3 weeks ago • Therapeutic advances in endocrinology and metabolism

GLP-1 receptor drugs linking metabolism and gut inflammation in type 2 diabetes and inflammatory bowel diseaseGLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease.

🎖️ Top 10% JournalEditorial

← prevpage 7 of 14next →

GLP-1 Therapies Research Papers